We are live on ! Find out more
BCAB icon

BioAtla
BCAB

73 hedge funds and large institutions have $208M invested in BioAtla in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more call options, than puts

Call options by funds: $3.34M | Put options by funds: $726K

211% more capital invested

Capital invested by funds: $67.1M → $208M (+$141M)

0.18% more ownership

Funds ownership: 1.31% → 1.49% (+0.18%)

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

4% less funds holding

Funds holding: 76 → 73 (-3)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
20
Reduced
22
Closed
25
Calls
$3.34M
Puts
$726K
Net Calls
+$2.61M
Net Calls Change
+$2.67M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$13.2M
2
CS
Candriam SCA
Luxembourg
+$10M
3
EAM
Eventide Asset Management
Massachusetts
+$5.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.01M
5
ACA
Avoro Capital Advisors
New York
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$9.2M
2
RCM
RA Capital Management
Massachusetts
-$2.94M
3
BBA
Baker Bros. Advisors
New York
-$2.35M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.94M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$33.5M +$13.2M +40,213 +86%
SCM
2
Soleus Capital Management
Connecticut
$26.2M +$902K +2,756 +4%
CAM
3
Cormorant Asset Management
Massachusetts
$16.8M +$936K +2,858 +7%
TCM
4
Tang Capital Management
California
$15.1M -$9.2M -28,119 -42%
CS
5
Candriam SCA
Luxembourg
$14.7M +$10M +30,567 +400%
Morgan Stanley
6
Morgan Stanley
New York
$12.7M +$3.72M +11,379 +53%
Vanguard Group
7
Vanguard Group
Pennsylvania
$10.8M +$1.73M +5,272 +23%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
8
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$6.62M +$2.83M +8,654 +101%
BlackRock
9
BlackRock
New York
$6.17M +$747K +2,281 +17%
EAM
10
Eventide Asset Management
Massachusetts
$6.12M +$5.2M +15,900 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$5.89M +$5.01M +15,294 New
BC
12
Boxer Capital
California
$5.29M – – –
ACA
13
Avoro Capital Advisors
New York
$4.43M +$3.76M +11,500 New
Renaissance Technologies
14
Renaissance Technologies
New York
$4.36M -$1.41M -4,296 -28%
ACM
15
Altium Capital Management
New York
$4.26M +$3.62M +11,060 New
Massachusetts Financial Services
16
Massachusetts Financial Services
Massachusetts
$4.09M +$236K +721 +7%
ACP
17
Acuta Capital Partners
California
$4M +$3.4M +10,400 New
Two Sigma Advisers
18
Two Sigma Advisers
New York
$2.76M -$398K -1,216 -15%
Deutsche Bank
19
Deutsche Bank
Germany
$2.3M +$982K +3,000 +101%
LCM
20
Laurion Capital Management
New York
$2.25M – – –
OMC
21
Oasis Management Company
Cayman Islands
$2.23M – – –
JP Morgan Chase
22
JP Morgan Chase
New York
$2.14M +$21.9K +67 +1%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$2.09M +$591K +1,805 +50%
Two Sigma Investments
24
Two Sigma Investments
New York
$1.99M -$1.49M -4,543 -47%
SCM
25
Silverarc Capital Management
Massachusetts
$1.54M +$1.31M +4,008 New
1
2 3 4

BCAB Hedge Fund Activity: Q3 2022 in Review

73 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q3 2022, worth a combined $208M — up 211% from $67.1M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BCAB and 22 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 20 added.

The largest buyer was Janus Henderson Group, adding an estimated $13.2M. The largest seller was Tang Capital Management, cutting an estimated $9.2M.

  • 73 institutional investors held BioAtla (BCAB) as of Q3 2022, down from 76 in Q2 2022.
  • Funds reported $208M of BioAtla stock for Q3 2022, up 211% quarter-over-quarter.
  • 22 funds opened new BioAtla positions in Q3 2022 and 25 closed out, a net change of -3 holders.
  • The largest BioAtla buyer in Q3 2022 was Janus Henderson Group, an estimated $13.2M added.
  • The largest BioAtla seller in Q3 2022 was Tang Capital Management, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2022.